ESR1 and neoplasm: In conclusion, our study highlighted a pivotal role of AD in suppressing the tumor progression of ER-positive breast cancer both in vitro and in vivo, and discovered a novel mechanism of AD down-regulating the expression of ER-α in ER-positive breast cancer and enhancing fulvestrant efficacy (Figure 6).